333 related articles for article (PubMed ID: 30540124)
1. Primary malignant tumors of the adrenal glands.
Almeida MQ; Bezerra-Neto JE; Mendonça BB; Latronico AC; Fragoso MCBV
Clinics (Sao Paulo); 2018 Dec; 73(suppl 1):e756s. PubMed ID: 30540124
[TBL] [Abstract][Full Text] [Related]
2. Update on the management of unusual neuroendocrine tumors: pheochromocytoma and paraganglioma, medullary thyroid cancer and adrenocortical carcinoma.
Strosberg JR
Semin Oncol; 2013 Feb; 40(1):120-33. PubMed ID: 23391119
[TBL] [Abstract][Full Text] [Related]
3. Clinical management of malignant adrenal tumors.
Kopf D; Goretzki PE; Lehnert H
J Cancer Res Clin Oncol; 2001; 127(3):143-55. PubMed ID: 11260859
[TBL] [Abstract][Full Text] [Related]
4. Metastatic pheochromocytoma and paraganglioma: recent advances in prognosis and management.
Hamidi O
Curr Opin Endocrinol Diabetes Obes; 2019 Jun; 26(3):146-154. PubMed ID: 30893083
[TBL] [Abstract][Full Text] [Related]
5. [Malignant tumors of the adrenal: contribution to the repository CCAFU INCa].
Sèbe P; Rigaud J; Avancès C; Brunaud L; Caillard C; Camparo P; Carnaille B; Culine S; Durand X; Mathonnet M; Mirallie E; Soulié M;
Prog Urol; 2010 Nov; 20 Suppl 4():S310-6. PubMed ID: 21129649
[No Abstract] [Full Text] [Related]
6. Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Berruti A; Baudin E; Gelderblom H; Haak HR; Porpiglia F; Fassnacht M; Pentheroudakis G;
Ann Oncol; 2012 Oct; 23 Suppl 7():vii131-8. PubMed ID: 22997446
[No Abstract] [Full Text] [Related]
7. Management of adrenocortical carcinoma.
Strosberg JR; Hammer GD; Doherty GM
J Natl Compr Canc Netw; 2009 Jul; 7(7):752-8; quiz 759. PubMed ID: 19635227
[TBL] [Abstract][Full Text] [Related]
8. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Fassnacht M; Assie G; Baudin E; Eisenhofer G; de la Fouchardiere C; Haak HR; de Krijger R; Porpiglia F; Terzolo M; Berruti A;
Ann Oncol; 2020 Nov; 31(11):1476-1490. PubMed ID: 32861807
[No Abstract] [Full Text] [Related]
9. Malignant adrenal tumors.
Rescorla FJ
Semin Pediatr Surg; 2006 Feb; 15(1):48-56. PubMed ID: 16458846
[TBL] [Abstract][Full Text] [Related]
10. Rare adrenal tumors in children.
Mihai R
Semin Pediatr Surg; 2014 Apr; 23(2):71-5. PubMed ID: 24931351
[TBL] [Abstract][Full Text] [Related]
11. Management of adrenal tumors in pregnancy.
Eschler DC; Kogekar N; Pessah-Pollack R
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):381-97. PubMed ID: 26038207
[TBL] [Abstract][Full Text] [Related]
12. [Recent advances in the treatment of adrenocortical carcinomas].
Ducry J; Berthold D; Pralong F
Rev Med Suisse; 2012 Nov; 8(362):2181-4, 2186. PubMed ID: 23240320
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and Management of Pheochromocytomas and Paragangliomas: A Guide for the Clinician.
Sharma S; Fishbein L
Endocr Pract; 2023 Dec; 29(12):999-1006. PubMed ID: 37586639
[TBL] [Abstract][Full Text] [Related]
14. A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features.
Ichijo T; Ueshiba H; Nawata H; Yanase T
Endocr J; 2020 Feb; 67(2):141-152. PubMed ID: 31694993
[TBL] [Abstract][Full Text] [Related]
15. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
[TBL] [Abstract][Full Text] [Related]
16. [Phaeochromocytoma and paraganglioma].
Cornu E; Belmihoub I; Burnichon N; Grataloup C; Zinzindohoué F; Baron S; Billaud E; Azizi M; Gimenez-Roqueplo AP; Amar L
Rev Med Interne; 2019 Nov; 40(11):733-741. PubMed ID: 31493938
[TBL] [Abstract][Full Text] [Related]
17. The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entity.
Chandrasekar T; Goldberg H; Klaassen Z; Wallis CJD; Woon DTS; Herrera-Caceres JO; Kulkarni GS; Fleshner NE
Cancer; 2019 Apr; 125(7):1050-1059. PubMed ID: 30561782
[TBL] [Abstract][Full Text] [Related]
18. The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management.
Lima JV; Kater CE
Int Braz J Urol; 2023; 49(3):307-319. PubMed ID: 37115176
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
Garcia-Carbonero R; Matute Teresa F; Mercader-Cidoncha E; Mitjavila-Casanovas M; Robledo M; Tena I; Alvarez-Escola C; Arístegui M; Bella-Cueto MR; Ferrer-Albiach C; Hanzu FA
Clin Transl Oncol; 2021 Oct; 23(10):1995-2019. PubMed ID: 33959901
[TBL] [Abstract][Full Text] [Related]
20. Pheochromocytoma/paraganglioma crisis: case series from a tertiary referral center for pheochromocytomas and paragangliomas.
Meijs AC; Snel M; Corssmit EPM
Hormones (Athens); 2021 Jun; 20(2):395-403. PubMed ID: 33575936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
